Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease

Manuela Neumann, Sigrun Roeber, Hans A. Kretzschmar, Rosa V Rademakers, Matt Baker, Ian R A MacKenzie

Research output: Contribution to journalArticle

195 Citations (Scopus)

Abstract

Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.

Original languageEnglish (US)
Pages (from-to)605-616
Number of pages12
JournalActa Neuropathologica
Volume118
Issue number5
DOIs
StatePublished - Nov 2009

Fingerprint

Intermediate Filaments
Cytomegalovirus Infections
Sarcoma
Pathology
Frontotemporal Lobar Degeneration
Basal Ganglia Diseases
Intranuclear Inclusion Bodies
Frontotemporal Dementia
Mutation
Inclusion Bodies
Movement Disorders
Neuroglia
Genes
Fluorescent Antibody Technique
Immunohistochemistry
Light

Keywords

  • Frontotemporal dementia
  • Frontotemporal lobar degeneration
  • Fused in sarcoma
  • Neuronal intermediate filament disease
  • Translocated in liposarcoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Cellular and Molecular Neuroscience

Cite this

Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. / Neumann, Manuela; Roeber, Sigrun; Kretzschmar, Hans A.; Rademakers, Rosa V; Baker, Matt; MacKenzie, Ian R A.

In: Acta Neuropathologica, Vol. 118, No. 5, 11.2009, p. 605-616.

Research output: Contribution to journalArticle

Neumann, Manuela ; Roeber, Sigrun ; Kretzschmar, Hans A. ; Rademakers, Rosa V ; Baker, Matt ; MacKenzie, Ian R A. / Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. In: Acta Neuropathologica. 2009 ; Vol. 118, No. 5. pp. 605-616.
@article{38e5df0e5cb44f2bbdddf85864523e1f,
title = "Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease",
abstract = "Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.",
keywords = "Frontotemporal dementia, Frontotemporal lobar degeneration, Fused in sarcoma, Neuronal intermediate filament disease, Translocated in liposarcoma",
author = "Manuela Neumann and Sigrun Roeber and Kretzschmar, {Hans A.} and Rademakers, {Rosa V} and Matt Baker and MacKenzie, {Ian R A}",
year = "2009",
month = "11",
doi = "10.1007/s00401-009-0581-5",
language = "English (US)",
volume = "118",
pages = "605--616",
journal = "Acta Neuropathologica",
issn = "0001-6322",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease

AU - Neumann, Manuela

AU - Roeber, Sigrun

AU - Kretzschmar, Hans A.

AU - Rademakers, Rosa V

AU - Baker, Matt

AU - MacKenzie, Ian R A

PY - 2009/11

Y1 - 2009/11

N2 - Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.

AB - Neuronal intermediate filament inclusion disease (NIFID) is an uncommon neurodegenerative condition that typically presents as early-onset, sporadic frontotemporal dementia (FTD), associated with a pyramidal and/or extrapyramidal movement disorder. The neuropathology is characterized by frontotemporal lobar degeneration with neuronal inclusions that are immunoreactive for all class IV intermediate filaments (IF), light, medium and heavy neurofilament subunits and α-internexin. However, not all the inclusions in NIFID are IF-positive and the primary molecular defect remains uncertain. Mutations in the gene encoding the fused in sarcoma (FUS) protein have recently been identified as a cause of familial amyotrophic lateral sclerosis (ALS). Because of the recognized clinical, genetic and pathological overlap between FTD and ALS, we investigated the possible role of FUS in NIFID. We found abnormal intracellular accumulation of FUS to be a consistent feature of our NIFID cases (n = 5). More neuronal inclusions were labeled using FUS immunohistochemistry than for IF. Several types of inclusions were consistently FUS-positive but IF-negative, including neuronal intranuclear inclusions and glial cytoplasmic inclusions. Double-label immunofluorescence confirmed that many cells had only FUS-positive inclusions and that all cells with IF-positive inclusions also contained pathological FUS. No mutation in the FUS gene was identified in a single case with DNA available. These findings suggest that FUS may play an important role in the pathogenesis of NIFID.

KW - Frontotemporal dementia

KW - Frontotemporal lobar degeneration

KW - Fused in sarcoma

KW - Neuronal intermediate filament disease

KW - Translocated in liposarcoma

UR - http://www.scopus.com/inward/record.url?scp=70449521091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449521091&partnerID=8YFLogxK

U2 - 10.1007/s00401-009-0581-5

DO - 10.1007/s00401-009-0581-5

M3 - Article

C2 - 19669651

AN - SCOPUS:70449521091

VL - 118

SP - 605

EP - 616

JO - Acta Neuropathologica

JF - Acta Neuropathologica

SN - 0001-6322

IS - 5

ER -